Search / Trial NCT06612320

Refusal to Participate in a Randomized Trial Involving Pregnancy and Childbirth: Factors Associated with Refusal and Reasons for Refusal and Acceptance

Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Sep 24, 2024

Trial Information

Current as of December 22, 2024

Recruiting

Keywords

Refusal Clinical Trial Factors Reasons Pregnancy Pre Eclampsia

ClinConnect Summary

This clinical trial is looking to understand why some women choose not to participate in a research study about pregnancy and childbirth. The main goal is to find out what factors might influence their decision to refuse participation, as well as to gather insights on why some women agree to take part. This research is taking place in France and is currently recruiting women aged 65 to 74 who have been invited to join a randomized trial related to their pregnancy or childbirth experience.

If you are a woman in this age group and have been approached to participate, you might be eligible to join the study. There are no specific exclusions, which means that all women offered the chance to participate are welcome to consider it. If you decide to take part, you can expect to share your thoughts and experiences regarding the invitation to join the trial. Your feedback will help researchers understand the different reasons behind acceptance and refusal, ultimately improving future studies in pregnancy and childbirth.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • The study will be offered to all women who have been offered to participate in a randomized trial relating to their pregnancy and/or childbirth in participating services.
  • Exclusion Criteria:
  • None

Trial Officials

Yoann Athiel, MD

Principal Investigator

Port-Royal Maternity - APHP

About Assistance Publique Hôpitaux De Paris

Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.

Locations

Paris, Idf, France

Clamart, Idf, France

Colombes, Idf, France

Paris, Idf, France

Paris, Idf, France

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0